We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of WaveLight Analyzer and Alcon LadarWave

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00863876
First Posted: March 18, 2009
Last Update Posted: June 29, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
WaveLight AG
March 17, 2009
March 18, 2009
June 29, 2010
March 2009
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00863876 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Comparison of WaveLight Analyzer and Alcon LadarWave
Not Provided
Comparison of repeated WaveLight Analyzer and Alcon LadarWave measurements in phakic and pseudophakic eyes.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample
healthy patients and patients following surgery, patients with keratoconus presenting for examination at the clinic
  • Healthy
  • Keratoconus
Not Provided
  • 1
    non-operated healthy eyes
  • 2
    eyes 1 months following LASIK
  • 3
    eyes 3-6 months following LASIK
  • 4
    eyes with spherical monofocal IOLs more than 3 months postop
  • 5
    eyes with aspherical monofocal IOLs more than 3 months postop
  • 6
    eyes with toric monofocal IOLs more than 3 months postop
  • 7
    eyes with diffractive multifocal IOLs more than 3 months postop
  • 8
    eyes with phakic IOLs more than 3 months postop
  • 9
    eyes with keratoconus
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
144
Not Provided
Not Provided

Inclusion Criteria:

  • healthy eyes or eyes with the study conditions

Exclusion Criteria:

  • age < 18, eye disorders other than mentioned above, participation in any other study,
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Germany
 
 
NCT00863876
S-388/2008
Yes
Not Provided
Not Provided
Mr. Peter Riedel, WaveLight AG
WaveLight AG
Not Provided
Not Provided
WaveLight AG
June 2010